Pediatric patients with dog bites presenting to US children's hospitals

Sriram Ramgopal1,2, Michelle L Macy3,4

  • 1Division of Pediatric Emergency Medicine, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 E Chicago Ave, Box 62, Chicago, IL, 60611, USA. sramgopal@luriechildrens.org.

Injury Epidemiology
|September 14, 2021
PubMed

Insights

Pediatric dog bites cause significant injuries, with younger White, non-Hispanic children facing higher risks. Further research into race and ethnicity factors is crucial for targeted prevention strategies.

Area of Science:

  • Pediatric Emergency Medicine
  • Injury Epidemiology
  • Public Health

Background:

  • Dog bites are a common cause of injury in children presenting to US pediatric hospitals.
  • Characterizing these injuries is essential for understanding their impact and developing targeted interventions.

Purpose of the Study:

  • To characterize pediatric dog bite injuries across US children's hospitals.
  • To identify factors associated with clinically significant dog bite injuries in children.

Main Methods:

  • A multicenter observational study was conducted across 26 pediatric hospitals from July 2010 to June 2020.
  • Data included 68,833 dog bite episodes in patients 18 years or younger.
  • Generalized linear mixed models identified factors associated with a composite outcome of clinically significant injuries.

Main Results:

  • 24.0% of pediatric dog bite cases resulted in clinically significant injuries.
  • Younger age, weekday injuries, and higher income quartiles were associated with increased odds of significant injuries.
  • Black patients, Hispanic/Latino ethnicity, and private insurance showed lower odds of significant injuries.

Conclusions:

  • Dog bites represent a significant pediatric injury mechanism.
  • Younger, White, non-Hispanic children are at higher risk for severe dog bite injuries.
  • Findings highlight the need for further investigation into race/ethnicity disparities and for targeted prevention efforts.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
49
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34